|Bid||5.19 x 4000|
|Ask||0.00 x 1100|
|Day's range||5.42 - 5.78|
|52-week range||5.18 - 21.48|
|Beta (5Y monthly)||1.72|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Looking for a way to hedge against runaway inflation? Small-cap stocks tied to nimble businesses that can quickly pivot during times of crisis are especially attractive at the moment. Since Oct. 27, 2021, the small-cap stock tracking Russell 2000 index is up 6.8%.
Ocular Therapeutix (OCUL) delivered earnings and revenue surprises of 11.54% and 0.19%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?